Generali Investments Management’s Transmedics TMDX Stock Holding History

Generali Investments Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$199K	Sell	2,996 -1,618	-35%	-$137K	0.04%	144
2026 Q1	$459K	Buy	4,614 +1,736	+60%	+$226K	0.11%	114
2025 Q4	$350K	Buy	2,878 +1,669	+138%	+$209K	0.07%	116
2025 Q3	$136K	Buy	+1,209	New	+$142K	0.03%	150

Other funds holding TMDX

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

ZCI

Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $5.7B AUM 35.76% 1-Year Est. Return

STAS

Strong Tower Advisory Services Minneapolis, Minnesota $558M AUM 13.89% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Generali Investments Management's TMDX Position: Q2 2026 in Review

Generali Investments Management reduced its Transmedics (TMDX) stake by 35% in Q2 2026, selling an estimated $137K and leaving 2,996 shares worth $199K. The position accounts for 0.04% of the portfolio, ranked #144.

Generali Investments Management first reported a position in TMDX in Q3 2025 and has held it in 4 quarters since. The position peaked at $459K in Q1 2026. 45 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

Generali Investments Management held 2,996 shares of Transmedics worth $199K as of Q2 2026.
Generali Investments Management sold 1,618 Transmedics shares in Q2 2026, an estimated $137K.
Transmedics made up 0.04% of Generali Investments Management's portfolio in Q2 2026, its #144 holding.
Generali Investments Management first reported a position in Transmedics in Q3 2025 and has held it in 4 quarters since.
Generali Investments Management's Transmedics position peaked at $459K in Q1 2026.
45 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Generali Investments Management's 13F filing for Q2 2026, filed 10 Jul 2026.